Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism [15]

Diabetes Care

Volumn 26, Issue 5, 2003, Pages 1647-1648

  Kuwasako, Takahiro ^a   Hirano, Ken Ichi ^a,b   Sakai, Naohiko ^a   Ishigami, Masato ^a   Hiraoka, Hisatoyo ^a   Yakub, Mohamed Janabi ^a   Yamauchi Takihara, Keiko ^a   Yamashita, Shizuya ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; FATTY ACID; INSULIN; LIPOPROTEIN; LONG CHAIN FATTY ACID;

DYSLIPIDEMIA; FATTY ACID METABOLISM; GENETIC DISORDER; HUMAN; INSULIN RESISTANCE; LETTER; LIPID METABOLISM; LIPOPROTEIN METABOLISM; POSTPRANDIAL STATE; PROTEIN DEFICIENCY;

EID: 0041667789     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.5.1647-a     Document Type: Letter

References (4)

1. Febbraio M, Hajjar DP, Silverstein RL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791, 2001
2. a, platelet lack detectable GP IV(CD36). Blood 76:1698-1703, 1990
3. Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y: CD36 deficiency associated with insulin resistance. Lancet 357:686-687, 2001
4. Yoshizumi T, Nozaki S, Fukuchi K, Yamasaki K, Fukuchi T, Maruyama T, Tomiyama Y, Yamashita S, Nishimura T, Matsuzawa Y: Pharmacokinetics and metabolism of iodine-123-BMIPP fatty acid analogue in normal and CD36-deficient subjects. J Nucl Med 41:1134-1138, 2000